BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


Bionest appoints Daniel Teper to head US operations

Advisory and management services provider to life science industry now offers European and US perspective in one-stop shop
 
New York, February 21, 2006 - Bionest Partners, a provider of advisory and management services to life science companies, announces today that Dr Daniel Teper has joined the company as Managing Director North America with effect from January 16, 2006.

Based in New York city, Teper, 46, brings over 20 years of experience as a corporate executive, a management consultant and an entrepreneur. Prior to joining Bionest Partners, he was Chief Global Officer of GSW Worldwide/inChord, the largest independent healthcare communications group. From 2001-2003, Teper was Vice-President in the New York office of ISO Healthcare Consulting, now part of Monitor Group. He led major corporate strategy and portfolio management assignments for leading pharmaceutical companies and created novel offerings in Strategic Marketing and R&D Management.
 
"Daniel's appointment is a major step in building Bionest's presence in North America," said Alain J. Gilbert, co-founder and Managing Partner. "We look forward to adding Daniel's experience to our services for leading and emerging healthcare clients on both sides of the Atlantic applying Bionest's model: shareholder value creation through a combination of strategy development and corporate finance advice."
 
"Bionest's presence in North America means that we can advise our clients not only with a global perspective but also with US specific insights and relationships," said Teper. "This combination is valuable to both US and non-US clients."
 
Teper will be moderating a session on the launch of human papilloma virus (HPV) vaccines with speakers from the National Institutes of Health, UNICEF, GSK and Merck at BIO 2006 in Chicago next April. Bionest will also host a top management forum for its clients and has a booth (2157) at the show.

Early in his career, Teper was Project Manager for the Global Product Portfolio Review at Novartis in Basel, working closely with McKinsey & Company and the senior R&D and commercial leadership of the company.

Teper's operational experience includes sales, marketing, new product management with Novartis in the US, as well as and general management positions with GlaxoSmithKline and Sanofi-Aventis in Europe. He also led global operations for several healthcare communication groups with responsibility for multi-country P&Ls, Merger & Acquisitions, global client relationships and oversight of major global brands.

He is the founder of 21 West, a New York based Executive Producer of Medical and Health programs for television and broadband Internet and was recently elected President of the Media Forum for Global Health, a non profit organization which promotes the use of television, cinema and new forms of visual media, to inform and educate the public around the world.
 
Teper graduated with a Doctor of Pharmacy degree from Paris XI University and holds a Master of Business Administration from INSEAD where he was the J. Salmon scholar.
 
About Bionest Partners: www.bionest.com
Bionest Partners provides advisory and management services to help biotechnology, specialty pharmaceutical and medical device companies and their shareholders maximize the value of their assets. The company, based in Paris, with offices in New York, and founded in 2003, has a broad customer base ranging from biotech start-ups to established companies in the biotech, medical device and pharmaceuticals fields. Bionest Partners has experience with around 70 clients including Abbott, Aventis Pasteur, Aventis Pharma, Biogen, ProStrakan, GSK, Idexx, Medtronic, Millennium, Pfizer and Novartis. The company offers a hands-on approach, and its areas of expertise include management consulting (strategy, organization, marketing, due diligence, surrogate management), corporate finance (private placement, IPO support, out-licensing, in-licensing, mergers and acquisitions), entry into Europe (assessment, strategy, go-it-alone/partnering, management support). Bionest has a strong and growing team of consultants as well as a network of associate members which it deploys to address specific client assignments.
 
BIONEST Partners
535 West 34th  Street
New York, NY 10001

Tel:  (646) 274- 1316
Mobile: (201) 658-6763
Fax: (646) 274- 1393

For further information, please contact:

Andrew Lloyd & Associates
Andrew Lloyd / Heidi Thompson
allo@ala.com  / heidi@ala.com
Tel: +44 1273 675 100

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.